Jose Lozada, MD
Gynecology · Carolina, PRNPI 1720063050
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,125 of the $1,444 with a category attached, or 77.9%. Merck accounts for 77.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,145 and has fallen 98.3% since, to $20 in 2025.
Across 11 payments — averaging $131.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- AbbVie$125
- Johnson & Johnson$59
- Ipsen Biopharmaceuticals, Inc$48
- PBG Puerto Rico LLC$35
- Exact Sciences$20
- plus $33 from 2 others
What the payments were for
- Speaking & faculty fees$1,12578%
- Food & beverage$31922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 1 | $1,125 |
| AbbVie | 1 | $125 |
| Johnson & Johnson | 3 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| PBG Puerto Rico LLC | 1 | $35 |
| Exact Sciences | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $20 |
| Verastem, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$1,125
How this compares
$1,444 in reported general payments places this provider in the 80th percentile of 50 gynecology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 369 | $11,457 |
| Clindamycin Phosphate | 106 | $8,688 |
| Terconazole | 247 | $8,184 |
| Alendronate Sodium | 843 | $5,853 |
| Tolterodine Tartrate ErTolterodine Tartrate | 75 | $4,539 |
| Ibandronate Sodium | 235 | $4,424 |
| Fluconazole | 689 | $3,319 |
| Ciprofloxacin Hcl | 150 | $898 |
| ValacyclovirValacyclovir Hcl | 21 | $672 |
| Acyclovir | 12 | $532 |
| Raloxifene Hcl | 15 | $508 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $370 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $73 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Carolina
- Juan Salgado MoralesSan Juan$39K
- Yolianne Lozada CaprilesSan Juan$9K
- Henry Rodriguez GinorioSan Juan$9K
- Luis FloresMayaguez$4K
- Jorge NegronSan Juan$3K
- Dalia Hernandez MedinaSan Juan$2K
- Marybel Gonzalez-BadilloSan Juan$2K
- Anabelle Ortiz-RiveraPonce$2K
- Hector Rosario ReyesCaguas$2K
- Luis Arroyo AguirrecheaManati$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.